Vaccinesurvey project

VACCINESURVEY

VACCINESURVEY project proposes a system that represents a formidable tool of unprecedented power to monitor the progress of different vaccination programs and experimentally validate record-based coverage data.

The Marie Skłodowska-Curie Actions aim to support the career development and training of researchers – with a focus on innovation skills – in all scientific disciplines through international and intersectoral mobility. The primary objective of the Research and Innovation Staff Exchange (RISE) scheme is to “promote international and inter-sector collaboration through research and innovation staff exchanges, and sharing of knowledge and ideas from research to market (and vice-versa) for the advancement of science and the development of innovation.”

Horizon 2020

Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available in the years 2014 to 2020 – in addition to the private investment it will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.

MSCA

Thanks to the Marie Skłodowska-Curie Actions (MSCA), Small and Medium-sized enterprises can now collaborate with academic research organisations, have access to their facilities and integrate some of their highly skilled researchers within the research projects of the company.

RISE

Being a RISE project, VACCINESURVEY is based on a number of scientific objectives and deliverables implemented through international and intersectoral staff exchange (secondments), thus maximising the impact of the action for knowledge sharing, skills development and long-term research collaboration.

VACCINESURVEY (Full title: Monitor population immunity against vaccine preventable diseases) is a 4-year Research and Innovation Staff Exchange – RISE project funded under the Marie Skłodowska-Curie Actions in Horizon 2020.